Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -204,749 | -178,840 | -197,484 | -173,143 | -97,591 |
| Depreciation Amortization | -636 | -1,009 | 2,026 | 2,062 | 1,447 |
| Accounts receivable | 24,773 | -22,778 | -39,914 | -1,960 | N/A |
| Accounts payable and accrued liabilities | -14,105 | -1,906 | 11,955 | 3,514 | 751 |
| Other Working Capital | 29,233 | -45,424 | -5,419 | 11,019 | 3,376 |
| Other Operating Activity | 40,904 | 58,152 | 58,536 | 24,411 | 13,491 |
| Operating Cash Flow | $-124,580 | $-191,805 | $-170,300 | $-134,097 | $-78,526 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,629 | -269,404 | 10,213 | 18,011 | -56,115 |
| PPE Investments | -7,154 | -9,146 | -2,475 | -3,135 | -845 |
| Investing Cash Flow | $-21,783 | $-278,550 | $7,738 | $14,876 | $-56,960 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 50,000 | N/A |
| Common Stock Issued | 186,424 | 382,608 | 318,731 | 7,455 | 137,991 |
| Other Financing Activity | 1 | -25,000 | -25,000 | 0 | 0 |
| Financing Cash Flow | $186,425 | $357,608 | $293,731 | $57,455 | $137,991 |
| Beginning Cash Position | 31,836 | 144,583 | 13,414 | 75,180 | 72,675 |
| End Cash Position | 71,898 | 31,836 | 144,583 | 13,414 | 75,180 |
| Net Cash Flow | $40,062 | $-112,747 | $131,169 | $-61,766 | $2,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,580 | -191,805 | -170,300 | -134,097 | -78,526 |
| Capital Expenditure | -7,154 | -9,171 | -2,553 | -3,135 | -1,086 |
| Free Cash Flow | -131,734 | -200,976 | -172,853 | -137,232 | -79,612 |